1. Home
  2. DVA vs NXT Comparison

DVA vs NXT Comparison

Compare DVA & NXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DVA
  • NXT
  • Stock Information
  • Founded
  • DVA 1994
  • NXT 2013
  • Country
  • DVA United States
  • NXT United States
  • Employees
  • DVA N/A
  • NXT N/A
  • Industry
  • DVA Misc Health and Biotechnology Services
  • NXT Semiconductors
  • Sector
  • DVA Health Care
  • NXT Technology
  • Exchange
  • DVA Nasdaq
  • NXT Nasdaq
  • Market Cap
  • DVA 10.8B
  • NXT 8.8B
  • IPO Year
  • DVA 1995
  • NXT 2023
  • Fundamental
  • Price
  • DVA $146.06
  • NXT $62.81
  • Analyst Decision
  • DVA Hold
  • NXT Buy
  • Analyst Count
  • DVA 4
  • NXT 20
  • Target Price
  • DVA $157.00
  • NXT $61.25
  • AVG Volume (30 Days)
  • DVA 752.6K
  • NXT 2.5M
  • Earning Date
  • DVA 08-05-2025
  • NXT 07-29-2025
  • Dividend Yield
  • DVA N/A
  • NXT N/A
  • EPS Growth
  • DVA 14.90
  • NXT 2.85
  • EPS
  • DVA 10.11
  • NXT 3.47
  • Revenue
  • DVA $12,968,524,000.00
  • NXT $2,959,197,000.00
  • Revenue This Year
  • DVA $6.51
  • NXT $13.51
  • Revenue Next Year
  • DVA $3.41
  • NXT $10.60
  • P/E Ratio
  • DVA $14.44
  • NXT $17.92
  • Revenue Growth
  • DVA 5.11
  • NXT 18.38
  • 52 Week Low
  • DVA $131.76
  • NXT $30.93
  • 52 Week High
  • DVA $179.60
  • NXT $67.87
  • Technical
  • Relative Strength Index (RSI)
  • DVA 56.00
  • NXT 55.04
  • Support Level
  • DVA $138.65
  • NXT $59.77
  • Resistance Level
  • DVA $144.07
  • NXT $63.64
  • Average True Range (ATR)
  • DVA 3.16
  • NXT 2.56
  • MACD
  • DVA -0.09
  • NXT -0.33
  • Stochastic Oscillator
  • DVA 75.61
  • NXT 42.05

About DVA DaVita Inc.

DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.

About NXT Nextracker Inc.

Nextracker (and its subsidiaries) is a leading provider of intelligent, integrated solar tracker and software solutions used in utility-scale and distributed generation solar projects around the world. Nextracker's products enable solar panels in utility-scale power plants to follow the sun's movement across the sky and optimize plant performance. Nextracker has operations in the United States, Mexico, Spain and other countries in Europe, India, Australia, the Middle East, Africa, and Brazil.

Share on Social Networks: